Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.

Neureiter D, Jäger T, Ocker M, Kiesslich T.

World J Gastroenterol. 2014 Jun 28;20(24):7830-48. doi: 10.3748/wjg.v20.i24.7830. Review.

2.

Epigenetic targeting in pancreatic cancer.

van Kampen JG, Marijnissen-van Zanten MA, Simmer F, van der Graaf WT, Ligtenberg MJ, Nagtegaal ID.

Cancer Treat Rev. 2014 Jun;40(5):656-64. doi: 10.1016/j.ctrv.2013.12.002. Epub 2014 Jan 3. Review.

PMID:
24433955
3.

Novel therapeutic targets for pancreatic cancer.

Tang SC, Chen YC.

World J Gastroenterol. 2014 Aug 21;20(31):10825-44. doi: 10.3748/wjg.v20.i31.10825. Review.

4.

Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.

Juergens RA, Rudin CM.

Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e295. Review.

5.

Epigenetic inactivation of DNA repair in breast cancer.

Nowsheen S, Aziz K, Tran PT, Gorgoulis VG, Yang ES, Georgakilas AG.

Cancer Lett. 2014 Jan 28;342(2):213-22. doi: 10.1016/j.canlet.2012.05.015. Epub 2012 May 23. Review.

PMID:
22634493
6.

Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.

Frank TS, Sun X, Zhang Y, Yang J, Fisher WE, Gingras MC, Li M.

Cancer Lett. 2015 Jul 10;363(1):1-6. doi: 10.1016/j.canlet.2015.04.009. Epub 2015 Apr 15. Review.

PMID:
25890222
7.

Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.

Fukushige S, Horii A.

Cancer Lett. 2014 Jan 28;342(2):231-7. doi: 10.1016/j.canlet.2012.03.022. Epub 2012 Mar 23. Review.

PMID:
22450751
8.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
9.

Epigenetic biomarkers for human cancer: the time is now.

Mulero-Navarro S, Esteller M.

Crit Rev Oncol Hematol. 2008 Oct;68(1):1-11. doi: 10.1016/j.critrevonc.2008.03.001. Epub 2008 Apr 21. Review.

PMID:
18430583
10.

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

Coppedè F, Lopomo A, Spisni R, Migliore L.

World J Gastroenterol. 2014 Jan 28;20(4):943-56. doi: 10.3748/wjg.v20.i4.943. Review.

11.

DNA methylation and cancer.

Gokul G, Khosla S.

Subcell Biochem. 2013;61:597-625. doi: 10.1007/978-94-007-4525-4_26. Review.

PMID:
23150269
12.

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.

Falahi F, van Kruchten M, Martinet N, Hospers GA, Rots MG.

Breast Cancer Res. 2014 Jul 29;16(4):412. doi: 10.1186/s13058-014-0412-z. Review.

13.

The role of epigenetic alterations in pancreatic cancer.

Sato N, Goggins M.

J Hepatobiliary Pancreat Surg. 2006;13(4):286-95. Review.

PMID:
16858539
14.

Molecular markers of pancreatic cancer: development and clinical relevance.

Fry LC, Mönkemüller K, Malfertheiner P.

Langenbecks Arch Surg. 2008 Nov;393(6):883-90. doi: 10.1007/s00423-007-0276-0. Epub 2008 Feb 12. Review.

PMID:
18266003
15.

Novel methylation biomarker panel for the early detection of pancreatic cancer.

Yi JM, Guzzetta AA, Bailey VJ, Downing SR, Van Neste L, Chiappinelli KB, Keeley BP, Stark A, Herrera A, Wolfgang C, Pappou EP, Iacobuzio-Donahue CA, Goggins MG, Herman JG, Wang TH, Baylin SB, Ahuja N.

Clin Cancer Res. 2013 Dec 1;19(23):6544-55. doi: 10.1158/1078-0432.CCR-12-3224. Epub 2013 Oct 2.

16.

Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.

Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, Cruceru ML, Albulescu R.

World J Gastroenterol. 2014 Aug 21;20(31):10790-801. doi: 10.3748/wjg.v20.i31.10790. Review.

17.

Pancreatic cancer: translational research aspects and clinical implications.

Ansari D, Chen BC, Dong L, Zhou MT, Andersson R.

World J Gastroenterol. 2012 Apr 7;18(13):1417-24. doi: 10.3748/wjg.v18.i13.1417.

18.

Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer.

El Maalouf G, Le Tourneau C, Batty GN, Faivre S, Raymond E.

Cancer Treat Rev. 2009 Apr;35(2):167-74. doi: 10.1016/j.ctrv.2008.10.002. Epub 2008 Nov 21. Review.

PMID:
19027240
19.

Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.

Nakamura J, Tanaka T, Kitajima Y, Noshiro H, Miyazaki K.

World J Gastroenterol. 2014 Sep 14;20(34):11991-2006. doi: 10.3748/wjg.v20.i34.11991. Review.

20.

[Pancreatic cancer stem cell].

Hamada S, Masamune A, Shimosegawa T.

Nihon Rinsho. 2015 May;73(5):844-9. Japanese.

PMID:
25985641
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk